The Second Wave of COVID-19 in India: A Personal Story
Dr. Alankrita Taneja watched from afar as her grandfather’s health declined in parallel with the health care system in New Delhi during the devastating second wave of COVID-19 in India.
Dr. Alankrita Taneja watched from afar as her grandfather’s health declined in parallel with the health care system in New Delhi during the devastating second wave of COVID-19 in India.
With improved survival benefits with ICIs and targeted therapies in metastatic NSCLC, the use of these agents has made its way into early-stage NSCLC.
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance…
Data from a single-arm phase 2 trial conducted in China showed that glecirasib produced a response rate of 48% in patients with advanced KRASG12C-mutated NSCLC…
Learn more about the faculty and program for the Monthly Plenary Series session.
ASCO’s new policy statement on SDOH supports practices that sustain and advance cancer health equity.
Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of…
Cancer cachexia-anorexia is a major clinical problem. Investigational new drugs, mainly aimed at the regulation of appetite and satiety in the hypothalamus/brainstem, are in development…